MediPharm Labs Expresses Concerns About Dissident Nominees' Qualifications Ahead of Shareholder Meeting MediPharm Labs raises alarms regarding the qualifications of dissident nominees for its board, highlighting deficiencies in experience and diversity ahead of the shareholder vote.

MediPharm Labs Expresses Concerns About Dissident Nominees' Qualifications Ahead of Shareholder Meeting #Canada #Toronto #MediPharm_Labs #Apollo_Technology #Cannabis_Sector

MediPharm Labs Releases Shareholders' Meeting Materials and Chair's Update MediPharm Labs Corp. has filed its proxy materials for the upcoming shareholder meeting on June 16, 2025, detailing its strategic progress and addressing dissident actions.

MediPharm Labs Releases Shareholders' Meeting Materials and Chair's Update #Canada #Cannabis #Toronto #shareholder_meeting #MediPharm_Labs

MediPharm Labs Releases Shareholder Letter Ahead of Annual Meeting MediPharm Labs has filed proxy materials and issued a letter from the Chair, urging shareholders to support the Board's recommendations ahead of the upcoming meeting.

MediPharm Labs Releases Shareholder Letter Ahead of Annual Meeting #Canada #Shareholders #Toronto #MediPharm_Labs #Chair's_Letter

MediPharm Labs Seizes Unique Opportunities Amid Cannabis Rescheduling Discussions in the US MediPharm Labs is strategically positioned to benefit from the potential rescheduling of cannabis in the United States. Their unique FDA registration sets them apart.

MediPharm Labs Seizes Unique Opportunities Amid Cannabis Rescheduling Discussions in the US #Canada #Toronto #FDA_Registration #MediPharm_Labs #Cannabis_Rescheduling

Urgent Need for Board Overhaul at MediPharm Labs Amid Financial Crisis Apollo Technology Capital has called for an urgent board change at MediPharm Labs, accusing current leadership of excessive compensation and poor management.

Urgent Need for Board Overhaul at MediPharm Labs Amid Financial Crisis #Canada #Toronto #MediPharm_Labs #Apollo_Capital #Board_Change

MediPharm Labs Raises Alarm Over Competency of Dissident Director Candidates MediPharm Labs has expressed significant reservations regarding the qualifications of four dissident nominees for its board, raising concerns about experience and governance.

MediPharm Labs Raises Alarm Over Competency of Dissident Director Candidates #Canada #Toronto #cannabis_industry #MediPharm_Labs #Apollo_Technology

MediPharm Labs Announces Governance Initiatives Ahead of Important Shareholder Meeting MediPharm Labs prepares for its Annual Meeting by filing critical proxy materials and sharing key updates with stakeholders about governance and strategy.

MediPharm Labs Announces Governance Initiatives Ahead of Important Shareholder Meeting #Canada #Shareholders #Toronto #MediPharm_Labs #Proxy_Materials

MediPharm Labs Addresses Recent Dissident Shareholder Claims and Concerns MediPharm Labs has responded to a dissident shareholder's proxy filing, outlining concerns about the claims made and reaffirming its commitment to growth.

MediPharm Labs Addresses Recent Dissident Shareholder Claims and Concerns #Canada #Toronto #MediPharm_Labs #Apollo_Technology #Regan_McGee

Apollo Technology Capital Proposes New Directors for MediPharm Labs After Years of Shareholder Losses Apollo Technology Capital has announced its plan to nominate six new directors for MediPharm Labs, citing a staggering 99% stock price drop and urgent need for leadership change after years of financial losses.

Apollo Technology Capital Proposes New Directors for MediPharm Labs After Years of Shareholder Losses #Canada #Toronto #Shareholder_Value #MediPharm_Labs #Apollo_Technology

MediPharm Labs Achieves Significant Revenue Growth in 2024 with Focus on International Expansion In 2024, MediPharm Labs reported a remarkable 27% increase in net revenue driven by international cannabis sales. Their path to profitability appears promising.

MediPharm Labs Achieves Significant Revenue Growth in 2024 with Focus on International Expansion #Canada #Toronto #financial_results #MediPharm_Labs #Cannabis_Sales

MediPharm Labs Sells Hope Facility to Rubicon Organics for $4.5M MediPharm Labs has agreed to sell its Hope Facility to Rubicon Organics for $4.5 million, enhancing its financial standing without operational disruption.

MediPharm Labs Sells Hope Facility to Rubicon Organics for $4.5M #Canada #Toronto #MediPharm_Labs #Rubicon_Organics #Hope_Facility

MediPharm Labs Ends Sale of Napanee Facility to Kensana Health, Retains Operations MediPharm Labs has officially cancelled the sale of its Napanee facility to Kensana Health due to unmet conditions in the purchase agreement. The company will maintain its operations.

MediPharm Labs Ends Sale of Napanee Facility to Kensana Health, Retains Operations #Canada #Toronto #Kensana_Health #MediPharm_Labs #Napanee_Facility

MediPharm Labs Offers Latest Insights on Sale of Napanee Facility to Kensana Health MediPharm Labs has updated details regarding the sale of its Napanee Facility to Kensana Health, promising an uninterrupted transition and compliance with regulations.

MediPharm Labs Offers Latest Insights on Sale of Napanee Facility to Kensana Health #Canada #Toronto #Kensana_Health #MediPharm_Labs #Napanee_Facility

MediPharm Labs Announces Strategic Partnership with Laboratório Teuto in Brazil's Medical Cannabis Market MediPharm Labs has secured a pivotal agreement with Laboratório Teuto to expand its footprint in Brazil’s burgeoning medical cannabis sector. This partnership underscores a commitment to high-quality cannabis solutions.

MediPharm Labs Announces Strategic Partnership with Laboratório Teuto in Brazil's Medical Cannabis Market #Brazil #MediPharm_Labs #Laboratório_Teuto #medical_cannabis #Goiás